7[7]Ketteler M,Bongartz P,Westenfeld R,et al.Association of low fetuin-A(AHSG)concentrations in serum with cardiovascular mortality in patients on dialysis:a crosssectional study[J].Lancet,2003,361(9360):827-833.
8[8]Heiss A,DuCbesne A,Denecke B,et al.Structural basis of calcification inhibition by alpha 2-HS glycoprotein/fetuin-A.Formation of colloidal calciprotein particles[J].J Biol Chem,2003,278(15):13333-13341.
9[9]Price PA,Thomas GR,Pardini AW,et al.Discovery of a high molecular weight complex of calcium,phosphate,fetuin,and matrix gamma-carboxyglutamic acid protein in the serum of etidronate-treated rats[J].J Biol Chem,2002,277(6):3926-3934.
10[10]Demetriou M,Binkert C,Sukhu B,et al.Fetuin/alpha2-HS glycoprotein is a transforming growth factor-beta type Ⅱ receptor mimic and cytokine antagonist[J].J Biol Chem,1996,271(22):12755-12761.
2Goodman WG, Goldin J, Kuizon BD, et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med, 2000, 342 : 1478-1483.
3Ketteler M, Bongartz P, Westenfeld R, et al. Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis:a cross-sectional study. Lancet,2003, 361 (9360) : 827-833.
4US Renal Data System (USRDS):1999 Annual Data Report.Bethesda, National Institute of Diabetes and Kidney Diseases,1999.
5Yokoyama K. Evaluation of coronary artery calcification in ESRD patients. Clin Calcium, 2004, 14:109-115.
6Block GA, Hulbert-Shearon TE, Levin NW, et al. Association of serum phosphorus and calcium ×phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis, 1998, 31:607-617.
7Levin NW, Hoenich NA. Consequences of hyperphosphatemia and elevated levels of the calcium-phosphorus product in dialysis patients. Curr Opin Nephrol Hypertens, 2001, 10:563 -568.
8Giachelli CM, Jono S, Shioi A, et al. Vascular calcification and inorganic phosphate. Am J Kidney Dis, 2001, 38 (4 Suppl 1 ) : S34-S37.
9Price PA, Lira JE. The inhibition of calcium phosphate precipitation by fetuin is accompanied by the formation of a fetuin-mineral complex. J Biol Chem, 2003, 278 : 22144-22152.
10Schafer C, Heiss A, Schwarz A, et al. The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. J Clin Invest, 2003,112 : 357-366.
10Block G A, Port F K. Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: recommendations for a change in, management [J ]. Am J Kidney Dis, 2000, 35(6) : 1226.
